GlassScriptPhysician profile
Trevor R Call
NPI 1558709774
$2,126.96
in general payments reported to CMS, 2019-2025
10 companies · $95.46 in 2025
The $95.46 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,703 · 2022: $33.45 · 2023: $207 · 2024: $87.98 · 2025: $95.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369 · Education: $21.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.92 |
| Education | $21.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,638.23 | 2019-2025 | Pangea, Gamma |
| Wright Medical Technology, INC. | $149.31 | 2019 | |
| Crossroads Orthopedics, LLC | $79.28 | 2023 | |
| Linvatec Corporation | $73.66 | 2024 | Biobrace 23mm |
| Heron Therapeutics, INC. | $65.74 | 2023 | Zynrelef |
| Mf Med | $51.60 | 2025 | |
| Vericel Corporation | $21.37 | 2023 | Maci |
| Avanos Medical | $16.79 | 2022 | |
| Boston Scientific Corporation | $16.66 | 2022 | |
| Solventum Corporation | $14.32 | 2024 | Prevena, V.A.C. Dermatac, Prevena Restor Arthroform |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Call listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.